Emerging role of cytoreductive prostatectomy in patients with metastatic disease

Traditionally, systemic androgen deprivation therapy (ADT) has been the primary treatment modality in metastatic prostate cancer (mPCa) while treatment of the primary tumor has been reserved for patients with clinically localized disease. Emerging data suggests that treating the primary tumor in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaber, Yasmeen, Reichard, Chad A., Chapin, Brian F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178312/
https://www.ncbi.nlm.nih.gov/pubmed/30363448
http://dx.doi.org/10.21037/tau.2018.06.06

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178312/
https://www.ncbi.nlm.nih.gov/pubmed/30363448
http://dx.doi.org/10.21037/tau.2018.06.06

Ejemplares similares